Gut · 1978 · 126 citations · 11 references
MedicinePathologyHepatitis PharmacotherapyHepatologyImmunopathologyChronic Liver DiseaseCirrhosisHepatic PathologyHepatocellular CarcinomaLiver DiseaseViral HepatitisAzathioprine UseChronic Viral HepatitisCirrhosis In Viral HepatitisComplications Of CirrhosisGallbladder CarcinomaHepatitis B Virus PersistencePrednisone UseViral Hepatitis-related Cirrhosis
A group of patients with only moderately active chronic hepatitis has been studied. The follow-up was long (mean 87 months). All patients except one were treated with prednisone and/or azathioprine. Of the hepatitis B virus positive patients two-thirds developed cirrhosis between the second and fifth year of evolution, while in the hepatitis B negative group this occurred in less than one-third. The transition to cirrhosis was clinically silent. The patients were all allowed to do their normal work except in the terminal stages of cirrhosis. Five patients died of causes related to the disease: three patients with cirrhosis and hepatocellular carcinoma, one with gallbladder carcinoma, and one from bleeding varices. The high incidence of tumour, especially liver-cell carcinoma, may be due to a cumulative effect of the presence of hepatitis B virus, cirrhotic transformation, and immuno-suppression. The other patients are currently in apparently good health.
11
A CLASSIFICATION OF CHRONIC HEPATITIS
J. De Groote, V. Desmet, P. Gedigk et al. · The Lancet · 1968 · 847 citations
Cancer Research: Some Forward Steps
H. H. Hennemann, U. Essers, G. Stecher · The Lancet · 1965 · 733 citations
Medicine, Cancer Biology, Oncology +11
AUSTRALIA ANTIGEN IN ACUTE AND CHRONIC LIVER DISEASE
Ralph Wright, R. W. McCollum, Gerald Klatskin · The Lancet · 1969 · 251 citations
HEPATITIS-ASSOCIATED ANTIGEN IN CHRONIC LIVER DISEASE
Roy Fox, Summyah Niazi, Sheila Sherlock · The Lancet · 1969 · 113 citations
M.E. Alpert, M. S. R. Hutt, Colin Davidson · The American Journal of Medicine · 1969 · 84 citations